Art Display Created by People with Epilepsy Highlights Benefits of Complementary Therapy

  Art Display Created by People with Epilepsy Highlights Benefits of
  Complementary Therapy

 Research Underway Exploring the Therapeutic Impact of Art Therapy for People
                                with Epilepsy

Business Wire

SAN DIEGO -- November 30, 2012

For the second year, Lundbeck and the Epilepsy Foundation (EF) will exhibit
artwork from Studio E: The Epilepsy Art Therapy Program at the American
Epilepsy Society (AES) Annual Meeting. Studio E offers weekly group art
therapy sessions for adults, teens and children with epilepsy where
participants work with licensed art therapists using a variety of artistic
media, including painting, sketching and sculpting over several sessions.
Overwhelmingly positive feedback for the Studio E program has inspired
upcoming research to further understand the potential benefits of art therapy
for people with epilepsy.

Made possible through a partnership between Lundbeck, a pharmaceutical company
committed to helping people with epilepsy, and the Epilepsy Foundation, Studio
E is an ongoing program in more than 20 cities across the country. Art therapy
is considered a complementary therapy, which is often defined as a therapeutic
practice that supports or enhances conventional medicine.^1

“This powerful program embodies the Epilepsy Foundation’s mission to provide
services that benefit people with epilepsy, and has been celebrated by our
affiliate network and participants,” said Philip Gattone, president and CEO of
the Epilepsy Foundation. “I have heard EF affiliates describe how participants
open up more in a few weeks of doing art therapy than they did in many years
of support groups. I’ve often been told that after the first session, the
floodgates opened, and it was as if participants had been waiting for an
opportunity like this.”

Program participants, art therapists, Epilepsy Foundation representatives and
others have reported positive outcomes after each art therapy program. These
accounts indicate the program has helped people with epilepsy express
difficult feelings, gain comfort engaging with others and build confidence. In
an effort to better validate these outcomes, plans are underway to use Studio
E as a platform to conduct research that may provide us with a more rigorous
understanding of the benefits the program.

The epilepsy community has been using complementary and alternative therapies
to address seizure disorders for decades. For instance, the ketogenic diet was
originally introduced in the 1920s^2, and the focus on complementary and
alternative therapies and how they may help people with epilepsy continues to
gain momentum. In the past year, literature reviews, books and additional
research have explored how therapies that reduce stress may benefit people
with epilepsy. ^3,4,5

“Through the creative process, art therapy provides people a non-verbal way to
identify, communicate and work towards resolving conflicts and problems, and
consequently to reduce stress, increase self-esteem and restore an internal
locus of control,” said Dr. Steven Schachter, professor of neurology, Harvard
Medical School and chief academic officer, Center for Integration of Medicine
and Innovative Technology. “Each of these outcomes can be helpful to persons
with epilepsy, particularly those who are struggling with the effects of
seizures, side effects, living with epilepsy and interpersonal relationships.
The 2013 program will provide a unique opportunity to prospectively measure
the impact of art therapy for people with epilepsy and help us understand how
to optimize art therapy for their benefit.”

This year’s display will be showcased at the Innovation Pavilion on Dec. 1-2
at the AES meeting, one of the prominent international meetings for healthcare
professionals supporting people with epilepsy, and will include more than 25
prints of artwork created during 2012 programs from across the country. People
can view artwork from the programs online, regularly updated with new work, by

“Lundbeck is privileged to partner with the Epilepsy Foundation. This program
underscores our commitment to helping the epilepsy community in ways that go
beyond traditional avenues,” said Daniel Brennan, vice president and general
manager-neurology, Lundbeck US. “To support a program that has an enduring
benefit for people with epilepsy is truly special and we look forward to
better understanding the depth of Studio E’s impact.”

About Studio E: The Epilepsy Art Therapy Program

In 2011, Lundbeck and the Epilepsy Foundation launched Studio E: The Epilepsy
Art Therapy Program to offer group art therapy sessions to people with
epilepsy. Hosted by more than 20 local Epilepsy Foundation affiliates across
the country, in partnership with Lundbeck, Studio E gives people the
opportunity to take part in multiple art therapy sessions with certified art

Studio E participants create art using a variety of mediums such as painting,
sketching and sculpting. The process allows them to strengthen their voice,
express emotions, and share their experiences. Subsequently, Studio E promotes
confidence in participants to generate ideas, create new relationships and
cultivate new interests moving forward. Studio E uses an open studio approach,
which promotes freedom of expression and open discussion.

In 2013, Lundbeck and the Epilepsy Foundation will introduce a research
component to the Studio E program, which will serve to better understand the
qualitative benefits of art therapy. This will aim to be the largest study of
patients with epilepsy and art therapy.

About the Epilepsy Foundation

The Epilepsy Foundation, a national nonprofit with affiliated organizations
throughout the United States, has led the fight against epilepsy since 1968.
The Foundation's mission is to stop seizures, find cures and overcome the
challenges created by epilepsy. For additional information, please visit

About Lundbeck in the U.S.

A wholly-owned subsidiary of H. Lundbeck A/S, Lundbeck in the U.S. is
headquartered in Deerfield, Illinois,and is committed to accelerating our
work in central nervous system (CNS) disorders, including challenging seizure
disorders. Additionally, Lundbeck employees actively support and participate
in hundreds of epilepsy awareness events each year as part of their ongoing
commitment to make a difference for those impacted by epilepsy. For more
information, please visit

About Lundbeck

H. Lundbeck A/S (LUN.CO, LUN DC, HLUYY) is an international pharmaceutical
company highly committed to improving the quality of life for people suffering
from psychiatric and neurological disorders. For this purpose, Lundbeck is
engaged in the research, development, production, marketing and sale of
pharmaceuticals across the world. The company's products are targeted at
disorders such as depression and anxiety, psychotic disorders, epilepsy and
Huntington's, Alzheimer's and Parkinson's diseases.

Lundbeck was founded in 1915 by Hans Lundbeck in Copenhagen, Denmark. Today
Lundbeck employs approximately 6,000 people worldwide. Lundbeck is one of the
world's leading pharmaceutical companies working with psychiatric and
neurological disorders. In 2011, the company's revenue was DKK 16.0 billion
(approximately EUR 2.2 billion or USD 3.0 billion). For more information,
please visit


1.What Is Complementary and Alternative Medicine? National Center for
    Complementary and Alternative Medicine Last accessed 11/5/12
2.Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening
    KATP Channels. Harvard University.
    Last accessed 11/6/12.
3.Devisnky O, Schachter S, Pacia S, Alternative Therapies for Epilepsy. New
    York, NY. Demos Medical Publishing. 2012
4.Arida RM, de Almeida AC, Cavalheiro EA, Scorza FA. Experimental and
    clinical findings from physical exercise as complementary therapy for
    epilepsy [abstract]. Epilepsy Behavior. 10/23/2012. Accessed 11/6/2012. PMID:
5.Maguire MJ. Music and epilepsy: A critical review. 2012; 53(14):947-961.
    5/21/12. Accessed 11/9/12.
    PMID: 22612325


Matt Flesch
Press spacebar to pause and continue. Press esc to stop.